#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Alexander Delp Email
Director, Product Operations . Aeglea BioTherapeutics
How to contact Alexander Delp
Join and see Alexander's contact info for free!Current Roles
Employees:
36Revenue:
$3.9MAbout
Aeglea is a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The Company is developing pegzilarginase, its lead investigational therapy, for the treatment of Arginase 1 Deficiency, as monotherapy in arginine-dependent cancers and in combination with an immune checkpoint inhibitor for small cell lung cancer. In addition, Aeglea has an active research pipeline of other human enzyme-based approaches in both therapeutic areas. For more information, please visit http://aegleabio.com.Aeglea BioTherapeutics Address
221 Crescent StreetAustin, TX
United States